365 - Exploring the Future of Genomics in Digital Health. Alan Robertson, ClearSKY Genomics

In this episode of Talking HealthTech, host Peter Birch interviews Alan Robertson, the founder of ClearSKY Genomics. Alan discusses the collaboration between ClearSKYGenomics and the Digital Health CRC, specifically focusing on the role of genomics in the broader digital health landscape. They delve into the challenges of translating genomic-based treatments into patient care and the importance of data interoperability in genomics. This episode offers valuable insights into the future of genomics and its impact on healthcare innovation and digital health.Key Takeaways:The importance of data interoperability and access in the field of genomics was highlighted. Genomic data may vary between healthcare systems, making it crucial to establish standardised protocols for sharing and utilising this data effectively.The integration of genomics into healthcare innovation and digital health, the potential for advancements in genomics to revolutionise patient outcomes and reshape healthcare practices was emphasised.Building relationships between technical aspects and policy in the genomics field is a challenge that needs to be addressed. By bridging this divide, genomics can play a more prominent role in shaping high-level decisions around data usage and policy-making.Loving the show? Leave us a review, and share it with someone who might get some value from it.Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits, and more exclusive content. For more information, visit talkinghealthtech.com/thtplus Mentioned in this episode:Sign Up to the Free Talking Healthtech NewsletterSign up to the free Talking HealthTech newsletter for weekly digital health news, events, jobs, partner updates and Pete’s take on what matters across the sector: talkinghealthtech.com/newsletter